Clinical Trial Update: A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase I safety study of a cancer vaccine for HLA-A2 positive advanced ovarian, breast, and prostate cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• ImmunoVaccine Technologies cancer vaccine

Snippet

Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.) | Conditions: Ovarian Neoplasms, Breast Neoplasms | Phase 1 | Status: COMPLETED